The fully differentiated cells of the rat mammary parenchyma, the ductal epithelial, alveolar, and myoepithelial cells, are distinguished by their ultrastructure and by their accumulation of immunocytochemically detectable marker proteins. The different cell types probably develop from primative ductal structures called terminal end buds, which are present in the developing rat mammary glands, and these structures contain relatively undifferentiated cells.
More recently, immunocytochemical stains have been used to distinguish the ductal epithelial, myoepithelial, and alveolar cell types. The epithelial cells are stained, for example, by antisera to milk fat globule membranes (6) and keratin monoclonal antibody LE61 (7) . The myoepithelial cells are normally stained by antisera to vimentin, actin, myosin (6, 8) , keratin monoclonal antibody LP34 (7, 9) , and by the lectins Griffonia simplicifolia-1 (GS-1) and pokeweed mitogen (10) . The basement membrane, which is closely associated with and possibly synthesized at least in part by the myoepithelial cells, stains with antisera to laminin, type IV collagen, and Thy-1 antigen (6, 8, 11, 12) . The secretory cells are characterized by being stained with peanut lectin (13) and, during lactation, with antisera to casein (14) .
In the rat, the development of the mammary parenchyma takes place predominantly after birth but before puberty (15) by the lengthening and branching of primative ducts within the mammary fat pad. During this period of growth, the ducts terminate in globular structures called terminal end buds (TEBs), which contain most of the dividing parenchymal cells (16) . The number of TEBs reaches a maximum in rats about 20 days old (16) , and thereafter the number rapidly declines as the TEBs differentiate to terninal ducts and alveolar buds (17) . The alveolar buds are the direct precursors of the secretory alveoli. The TEBs consist of a heterogeneous collection of cells that show a gradation in ultrastructural and immunocytochemical-staining characteristics toward the epithelial cells within the cortex of the TEB on the one hand, and to the myoepithelial cells of the subtending duct on the other hand (18, 19) . Although it is probable that all the alveolar cells may arise from differentiation events within the TEBs and alveolar buds, it is not entirely clear whether all the myoepithelial cells arise in this way.
Myoepithelial cells are absent from the developing ducts of the mammary glands of young rodents until about 7 days after birth (6, 20) . Dissection of part of the rodent mammary gland and transplantation to other suitable sites in syngeneic animals results in the generation of fully developed mammary glands at the sites of implantation. These implanted glands will secrete milk products in isologous, pregnant hosts (21, 22) , suggesting a reversible state between ductal and alveolar cells. Bud-free ducts dissected from rat mammary glands can regenerate the entire mammary parenchyma including the TEBs (23) and casein-producing alveoli in appropriate hosts (24) . These facts raise the possibility that fully differentiated myoepithelial cells may also arise from cells present within the bud-free ducts.
The susceptibility of the rat mammary gland to chemical carcinogenesis correlates with the presence in the gland of TEBs and terminal ducts (25) . The tumors induced by dimethylbenzanthracene (DMBA) (26) or nitrosomethyl urea (NMU) (27) are predominantly cytologically benign in the authors' experience (28) . These relatively benign tumors contain areas of epithelial and elongated, myoepitheliallike cells in ductlike arrangements (29) . However, many of the elongated, myoepitheliallike cells possess a more undifferentiated appearance than the myoepithelial cells of mature mammary ducts (30) . Hormonal stimulation of the host leads to production of a small proportion of alveolarlike cells that can synthesize casein (31) . However, the amount of casein and casein mRNA produced by these cells is only 1 to 5% of that produced by the alveolar cells of the lactating mammary glands in normal rats, when animals bearing the tumors are subsequently mated (14, 31, 32) .
Morphological Differentiation of Cultured Normal and Tumorous Mammary Stem Cells
Limited digestion of carcinogen-induced benign mammary tumors, or normal mammary glands, yields organoids that will subsequently adhere to the surface of a tissue culture vessel, providing that their basement membrane has not been destroyed. The stromal cells adhere to the substratum after about 2 hr, and the epithelial fraction adhers after 12 to 24 hr (33, 34) . After several days in culture, epithelial cells grow from the organoids and single epithelial cells can be cloned (35) . Such single-cellcloned epithelial cell lines have been obtained from the normal mammary glands of 7-day-old inbred, FurthWistar rats (36) , from DMBA-induced tumors of outbred Sprague-Dawley rats (35) or inbred, Furth-Wistar rats (37) , and from an NMU-induced rat mammary tumor (38) . All the cell lines derived from the normal mammary glands or benign tumors behave in a similar way. Thus, the work on the benign tumor-derived epithelial cell line Rama 25 is described in detail.
Sequential Changes Associated with Differentiation to Alveolarlike Cells In Vitro
Rama 25 cells grow on collagen gels and form branched, ductlike structures with a correctly organized basement membrane (39) . Such structures are reminiscent of the immature ducts found in neonatal rat mammary glands. That the Rama 25 cell line can form such ductlike structures suggests that it may represent a mammary stem cell. However, Rama 25 cells are more conveniently cultured on a plastic substratum on which they grow with a cuboidal, epithelial morphology. When such cultures, growing in the presence of hydrocortisone and insulin, become densely packed, small, dark, polygonal cells are formed (35) that contain vacuoles or droplets at their peripheries (droplet cells). These cells form hemispherical blisters or domes that are thought to arise from the unidirectional pumping action of the ouabain-sensitive sodium/potassium ATPase (40) .
The pathway of morphological differentiation in vitro to the droplet/doming cultures takes place through a linear sequence of morphological stages in the order cuboidal, grey, dark, dark-droplet, and doming cells (41) . The overall process can be accelerated by the addition of the erythroleukemic cell-differentiation inducer, dimethyl sulfoxide (35, 42) , or by retinoic acid (43) in the presence of the mammotrophic hormones prolactin, estrogen, hydrocortisone, and insulin. The doming cultures can synthesize rat casein as detected by radioimmunoassay and this casein has a peptide map identical to that of rat P-casein (44) . However, the amount of casein produced by Rama (46) , and subconfluent cultures yield 1 to 3% of clones of cells with an elongated morphology (35) . The formation of similar morphological forms occurs also in cultures of mouse mammary tumors (47) (48) (49) and in cultures of normal rat mammary glands (36) . From a comparison of the ultrastructure and immunocytochemical staining characteristics of histological sections of rat mammary glands (39, 46) and of their primary cultures (50) , the elongated cells derived from cultures of cell line Rama 25 are thought to be related to myoepithelial cells.
In primary cultures, myoepithelial cells stain with antisera to vimentin (50) , Thy-i (24), lami'nin, type IV collagen (50, 51) , and the lectins GS-1 and pokeweed mitogen (10), similar to the staining of myoepithelial cells and basement membranes in vivo. However, there are some differences; thus, antisera to actin and myosin stain only some of the elongated, myoepitheliallike cells in primary culture (50) . In a similar fashion to the primary culture:s, the elongated, myoepitheliallike converts from the cloned mammary epithelial cell lines always express vimentin, laminin, type IV collagen, Thy-i (12, 46, (52) (53) (54) (55) , and receptors for the lectins GS-1 and pokeweed mitogen (10) . But, as with primary cultures, some elongated cell clones stain well with actin and myosin; others (e.g., Rama 29 cells) stain poorly (56) . In general, cells of a more mature myoepithelial phenotype have been derived from the epithelial cells of normal rat mammary glands, for example, cell lines Rama 704E (36) and Rama 401 (54) , than from the epithelial cells of mammary tumors, for example, Rama 29 (35) and Rama 37E5 (37) . This result is consistent with the finding that the better differentiated myoepithelial cells occur in normal mammary glands rather than in their tumors. Moreover, subcloning of the better-differentiated myoepitheliallike cell lines in vitro can also lead to a further loss of the microfi'lamental systems and to a less differentiated cellular phenotype (57) . Thus, based on these results, the majority of the more elongated cells in vitro are classified as myoepitheliallike rather than as mature myoepithelial cells (58) .
Polypeptide Changes Associated with the Differentiation to Myoepitheliallike Cells In Vitro
The conversion in culture of the cuboidal, epithelial cells to elongated myoepitheliallike cells is accompanied by changes in a small number of specific polypeptides. Essentially the same changes are also found for the conversion of epithelial cells derived from normal glands or from benign tumors to the elongated myoepitheliallike cells (55) . The pattern of acidic polypeptides from the elongated, myoepitheliallike cell line, Rama (61) . It is complementary to 400 bases at the 3' end of the p9Ka mRNA. This cloned cDNA has been used to screen a genomic library containing fragments of rat liver DNA. An 18-kilobase fragment of rat genomic DNA that contains the p9Ka gene and its flanking regions has been isolated from the recombinant library (62) . The sequence of 2340 nucleotides of this gene region has been determined (Fig. 2) , and a potential amino acid sequence for p9Ka has been deduced from the nucleotide sequence data. A polypeptide corresponding to a linear sequence of 12 amino acids from this deduced sequence was synthesized, chemically coupled to keyhole limpet hemocyanin, and injected into rabbits. The resulting antiserum crossreacts with denatured p9Ka separated from other cellular proteins by two-dimensional gel electrophoresis (63, 64) . It also shows the same staining pattern on sections of rat mammary glands as the antiserum raised against the purified preparations of p9Ka (60) .
The p9Ka gene sequence (Fig. 2) contains at least one intervening sequence, or intron, with boundaries that can be located precisely, because the intervening sequence is flanked by DNA corresponding to the cloned cDNA to p9Ka mRNA (Fig. 2) . The 5' and 3' boundaries of this intron conform to concensus intron/exon boundary sequences (65) . A poly(A) addition signal, AATAAA, is present at bases numbered 2176 to 2181, and the mRNA ends at base number 2194. Six separate start sites for the mRNA have been located to a small region of the DNA between bases numbered 834 and 884. The size of the p9Ka mRNA is thus 629 to 680 nucleotides and is consistent with the actual size of 700 to 780 nucleotides including the poly(A) tail, when measured following agarose gel electrophoresis (61 acids, excluding the initiating methionine residue and ends with two termination codons. The potential amino acid sequence for p9Ka is shown in Figure 3 . A search of computerized data bases of protein and nucleic acid sequences shows limited homology (66) of this potential p9Ka amino acid sequence to both the a (43%) and P (43%) chains of bovine S-100 protein (67, 68) and to rat S-100 protein (42%) (69) . This homology is also observed in the corresponding nucleic acid sequences. A cloned cDNA corresponding to a portion of rat S-100 pro- Cys-Asn-Glu-Phe-Phe-Glu-Gly-Cy-Pro-Asp-Lys-Glu-Pro-Arg-Lys-Lys Bov. CaBP.
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Lys-Ile-Ser-Gln tein mRNA (69) has an overall homology of 66% with the corresponding region of the p9Ka gene. The protein p9Ka also shows a weak homology (34%) with the bovine vitamin D-dependent, intestinal calciumbinding protein (Fig. 3) (70) . This protein has two potential calcium-binding sites, one of which conforms to the EF-hand structure of known calcium-binding proteins (71, 72) . When only those amino acid residues thought to be involved in calcium binding by the two sites of bovine intestinal protein (72) are compared with those in similar positions in p9Ka, 11 out of 14 of these residues are identical in the two polypeptides. The protein p9Ka also contains two potential calcium-binding loops between residues 33 and 40 and residues 62 and 73 (Fig. 3) . The Cterminal loop (residues 62-73) of p9Ka corresponds to an almost perfect EF-hand sequence, with five residues containing carboxylic acid derivatives in their side chains (aspartate 62, asparagine 64, aspartate 66, aspartate 70, glutamate 73 of the p9Ka amino acid sequence) in the exact positions of the loop region that are thought to be important in calcium binding by the vitamin D-dependent, intestinal calcium-binding protein (72, 73) . In p9Ka this potential binding site contains asparagine at position 67 instead of the smaller glycine residue. This latter residue is thought to play a role in maintaining the EF-hand structure in both S-100 protein and intestinal calciumbinding protein (74) . However, this particular substitution may not prevent calcium binding by p9Ka, since the other, N-terminal loop of the intestinal calcium-binding protein also binds calcium, but does not contain this particular glycine residue (72).
It is not yet known whether one or both of the potential calcium-binding sites in p9Ka bind calcium under experimental or physiological conditions, or whether, as in the case of the S-100 protein, calcium binding is modulated by the presence of other cations, such as potassium and magnesium (75) . The relative positions of the two potential binding sites in p9Ka are similar to those in a number of other small putative calcium-binding proteins (Fig. 4) . The gene sequences corresponding to these proteins are not yet available. However, in the case of the gene for p9Ka the single intron interupts the hypothetical coding region in the linker between the two potential calcium-binding sites, thus separating the two functional domains (62) .
In contrast, the genes of proteins with four calciumbinding sites, such as those of calmodulin (76) and Spec 1 protein (77), contain multiple introns that often interrupt the calcium-binding domains (Figs 4 and 5) . Whether all the small calcium-binding proteins have the same intron/exon arrangement is not known. It is interesting to speculate that the cytoskeletal rearrangement on differentiation of Rama 25 stem cells to the elongated myoepitheliallike cells (53) (55) is accompanied by only a 10-fold increase in p9Ka cytoplasmic mRNA (61) . These results suggest that translational control may play a facilitating role in the increase in p9Ka. On the other hand, the 3.7-fold increase in laminin (56) and the 3.5-fold increase in type IV collagen (79) are accompanied by only a very small increase in their respective mRNAs ( Table  1 ). The increase in type IV collagen seen in elongated, myoepitheliallike cells relative to the cuboidal, epithelial cells arises predominantly from a 5-fold decrease in the rate of intracellular breakdown of type IV collagen, estimated from the rate of release of hydroxyproline (79) . The combination of these results strongly suggests that in the same cells, the steady-state levels of different marker proteins can arise by altering control at different molecular levels, including that at transcriptional, posttranscriptional processing or posttranslational steps. It has not yet been possible to determine whether the altered levels of Thy-1 mRNA arise from altered control at the initiation of transcription or at processing of the Thy-1 mRNA transcripts. These two levels of control can be distinguished by measuring the rate of completion of nascent RNA transcripts by isolated cell nuclei. However, in our experiments so far, Thy-1 RNA transcripts can be detected at only very low levels in nuclei from the elongated, myoepitheliallike cells and from the cuboidal epithelial cells. Under the same conditions, RNA transcripts corresponding to two other cellular mRNAs are readily detected (80). Thus, it is possible that putative factors necessary for the transcription of Thy-1 mRNA are lost during isolation of the nuclei from the elongated, cultured cells, but, at present, their identity is completely unknown.
In the case of p9Ka, preliminary evidence suggests that at least part of the increase in its accumulation in the myoepitheliallike cells in vitro arises from an increased rate of transcription of its mRNA when compared to the cuboidal epithelial cells (unpublished observation). In many genes, regions of DNA important in controlling the synthesis of their mRNA molecules are often located immediately adjacent to those sequences corresponding to the 5' end of the mRNA. These regions, such as the TATA (81) and CAAT (82) concensus sequences are thought to be important in specifying the start site of transcription of the gene by RNA polymerase. However, no obvious TATA or CAAT promoter sequences are found close to the region corresponding to p9Ka mRNA. Genes that do not possess promoters that contain TATA or CAAT concensus sequences in either the coding or the noncoding strand of DNA have been identified recently (83) (84) (85) (86) (87) . In at least two of these cases, the murine Thy-1,2 gene (85, 87) and the 3-hydroxy-3-methylglutaryl coenzyme A reductase gene (84) multiple initiation sites for the transcription of the mRNAs have been reported, similar to those found for the mRNA for p9Ka. The absence of TATA and CAAT promoter sequences is a characteristic of certain housekeeping genes (84) that possess promoter regions rich in GC nucleotide pairs, and short sequences, GGGCGG, homologous to part of the 21 nucleotide-pair repeat of the promoters for SV40 specific mRNAs (84, 86) . However, although the 5' sequence flanking the gene for p9Ka does contain some G-rich regions, the above elements are absent. Thus, it is possible that the gene for p9Ka may contain a novel promoter that regulates its expression be- 
